Noile-Immune Biotech Inc. (TYO:4893)
77.00
-4.00 (-4.94%)
Nov 18, 2026, 11:08 AM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 3.34 billion as of November 17, 2026. It is the 35,897th most valuable company in the world and the 3,301st biggest in Japan. Its market cap has decreased by 50.21% in one year.
Market Cap
3.34B
Enterprise Value
8.73M
Revenue
n/a
Global Rank
Country Rank
#3,301 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 3.34B, a decrease of -89.18%. That is a compound annual growth rate of -48.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 3.34B | -41.98% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 4.84B |
| Kringle Pharma | 4.44B |
| SUSMED,Inc. | 4.25B |
| Kohjin Bio | 3.34B |
| Chordia Therapeutics | 3.33B |
| Modalis Therapeutics | 3.30B |
| Transgenic Group | 3.23B |
| PRISM BioLab Co.,LTD | 3.22B |